Literature DB >> 28969570

New Perspectives of Alzheimer Disease Diagnosis - the Most Popular and Future Methods.

Katarzyna Pietrzak1, Kamila Czarnecka1, Elzbieta Mikiciuk-Olasik1, Pawel Szymanski1.   

Abstract

As lifespan tendency is increasing, age-related diseases are becoming a burden to the society and health care system. Mostly incurable, constitute a subject of researchers' work. In this review, the insight into the problem of Alzheimer Disease (AD) diagnostics will be given. The unquestionable diagnosis is possible only during a post-mortem examination. AD is known as one of the forms of dementia and its differentiation from mild cognitive impairments has to be improved. Despite a great diagnostic progress during last decades, medicine still needs more accurate tools for an early detection of this incurable disease. It is hoped that this strategy will enable an administration of more aggressive therapy preventing AD development. Nowadays, pharmacotherapy is based mainly on symptomatic treatment which is not able to reverse pathological changes caused by the disease. Hence, more accurate identifying testing and monitoring methods are crucial to reveal new therapeutic targets. The most popular techniques present for detecting local brain functional changes use nuclear medicine imaging devices: Positron Emission Tomography (PET) and Single Photon Emission Computed Tomography (SPECT). Constant process of improving is not possible without new radiotracers. Magnetic Resonance Imaging (MRI) is a tool for an assessment of structural changes in brain tissue. However, providing satisfying results, these methods are not completely specific and accurate. As very promising hallmarks of AD enhancing high accuracy of testing, biomarkers - tau tangles and β-amyloid plaques have been found. At the present time they are being used only as an additional examination, one day they may become a gold standard of AD diagnostics. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Alzheimer's disease; MRI; PET; SPECT; biomarkers; diagnosis of alzheimer's disease

Mesh:

Year:  2018        PMID: 28969570     DOI: 10.2174/1573406413666171002120847

Source DB:  PubMed          Journal:  Med Chem        ISSN: 1573-4064            Impact factor:   2.745


  7 in total

Review 1.  A short perspective on the long road to effective treatments for Alzheimer's disease.

Authors:  David S Reynolds
Journal:  Br J Pharmacol       Date:  2019-03-01       Impact factor: 8.739

Review 2.  Computational Techniques for Eye Movements Analysis towards Supporting Early Diagnosis of Alzheimer's Disease: A Review.

Authors:  Jessica Beltrán; Mireya S García-Vázquez; Jenny Benois-Pineau; Luis Miguel Gutierrez-Robledo; Jean-François Dartigues
Journal:  Comput Math Methods Med       Date:  2018-05-20       Impact factor: 2.238

3.  Picomolar-sensitive β-amyloid fibril fluorophores by tailoring the hydrophobicity of biannulated π-elongated dioxaborine-dyes.

Authors:  Jusung An; Peter Verwilst; Hira Aziz; Jinwoo Shin; Sungsu Lim; Ilwha Kim; Yun Kyung Kim; Jong Seung Kim
Journal:  Bioact Mater       Date:  2021-11-09

4.  Rational design and synthesis of a novel BODIPY-based probe for selective imaging of tau tangles in human iPSC-derived cortical neurons.

Authors:  Alessandro Soloperto; Deborah Quaglio; Paola Baiocco; Isabella Romeo; Mattia Mori; Matteo Ardini; Caterina Presutti; Ida Sannino; Silvia Ghirga; Antonia Iazzetti; Rodolfo Ippoliti; Giancarlo Ruocco; Bruno Botta; Francesca Ghirga; Silvia Di Angelantonio; Alberto Boffi
Journal:  Sci Rep       Date:  2022-03-28       Impact factor: 4.379

5.  Smart-Data-Driven System for Alzheimer Disease Detection through Electroencephalographic Signals.

Authors:  Teresa Araújo; João Paulo Teixeira; Pedro Miguel Rodrigues
Journal:  Bioengineering (Basel)       Date:  2022-03-28

6.  Gold Nanoparticles Mediate Improved Detection of β-amyloid Aggregates by Fluorescence.

Authors:  Pedro Jara-Guajardo; Pablo Cabrera; Freddy Celis; Mónica Soler; Isadora Berlanga; Nicole Parra-Muñoz; Gerardo Acosta; Fernando Albericio; Fanny Guzman; Marcelo Campos; Alejandra Alvarez; Francisco Morales-Zavala; Marcelo J Kogan
Journal:  Nanomaterials (Basel)       Date:  2020-04-06       Impact factor: 5.076

Review 7.  Plasmonic Nanoparticles as Optical Sensing Probes for the Detection of Alzheimer's Disease.

Authors:  María Paz Oyarzún; Andreas Tapia-Arellano; Pablo Cabrera; Pedro Jara-Guajardo; Marcelo J Kogan
Journal:  Sensors (Basel)       Date:  2021-03-16       Impact factor: 3.576

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.